Video

Conversations on Patient Priorities and Preferences Should Take Place Before Treatment

With so many cancer treatment options now available, clinicians may still fall short in understanding what’s important to patients.

With so many treatment options now available, clinicians may still fall short in incorporating the priorities and preferences of patients into treatment, according to Ellen Miller-Sonet.

At the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, Sonet — who is the chief strategy and policy officer for CancerCare® — discussed the conversations that should be taking place between patients and their physician before cancer treatment even begins.

“Both the clinician and the patient need to have a conversation so that treatment options can be eliminated if they’re really inappropriate for what’s important to the patient,” she said.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
Image of two doctors and text.
Imiage of two doctors with text.
Image of two doctors and text.
Image of patient and doctor.
Image of two doctors with text.
image of gerds
Related Content